Gene · 337
Papers3,283
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,283
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Small extracellular vesicles obtained from hypoxic mesenchymal stromal cells have unique characteristics that promote cerebral angiogenesis, brain remodeling and neurological recovery after focal cerebral ischemia in mice. | Basic Res Cardiol | 2021 | 34105014 | PubTator, text mining | PubMed |
| HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research. | Circulation | 2021 | 34097448 | PubTator, text mining | PubMed |
| Construction of a Human Cell Landscape of COVID-19 Infection at Single-cell Level. | Aging Dis | 2021 | 34094635 | PubTator, text mining | PubMed |
| Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues: A Transcriptomic and Proteomic Study. | Front Immunol | 2021 | 34093520 | PubTator, text mining | PubMed |
| Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis. | Lipids Health Dis | 2021 | 34078402 | PubTator, text mining | PubMed |
| Proteomic Analyses of Vitreous in Proliferative Diabetic Retinopathy: Prior Studies and Future Outlook. | J Clin Med | 2021 | 34070658 | PubTator, text mining | PubMed |
| Gynecology Meets Big Data in the Disruptive Innovation Medical Era: State-of-Art and Future Prospects. | Int J Environ Res Public Health | 2021 | 34064710 | PubTator, text mining | PubMed |
| Metabolic Reprogramming: Strategy for Ischemic Stroke Treatment by Ischemic Preconditioning. | Biology (Basel) | 2021 | 34064579 | PubTator, text mining | PubMed |
| Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins. | Biomedicines | 2021 | 34064071 | PubTator, text mining | PubMed |
| Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications. | J Clin Med | 2021 | 34063950 | PubTator, text mining | PubMed |
| Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence. | Diagnostics (Basel) | 2021 | 34063765 | PubTator, text mining | PubMed |
| Host Response of Atlantic Salmon (Salmo salar) Re-Inoculated with Paramoeba perurans. | Microorganisms | 2021 | 34062978 | PubTator, text mining | PubMed |
| Proteomic and transcriptional changes associated with MeCP2 dysfunction reveal nodes for therapeutic intervention in Rett syndrome. | Neurochem Int | 2021 | 34048843 | PubTator, text mining | PubMed |
| Charting human development using a multi-endodermal organ atlas and organoid models. | Cell | 2021 | 34019796 | PubTator, text mining | PubMed |
| Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches. | Biomark Insights | 2021 | 34017167 | PubTator, text mining | PubMed |
| Transcriptome responses in polar cod (Boreogadus saida) liver slice culture exposed to benzo[a]pyrene and ethynylestradiol: insights into anti-estrogenic effects. | Toxicol In Vitro | 2021 | 34015484 | PubTator, text mining | PubMed |
| Agrobacterium tumefaciens Growth Pole Ring Protein: C Terminus and Internal Apolipoprotein Homologous Domains Are Essential for Function and Subcellular Localization. | mBio | 2021 | 34006657 | PubTator, text mining | PubMed |
| Serum biomarker discovery related to pathogenesis in acute coronary syndrome by proteomic approach. | Biosci Rep | 2021 | 34002800 | PubTator, text mining | PubMed |
| Taming the Huntington's Disease Proteome: What Have We Learned? | J Huntingtons Dis | 2021 | 33998547 | PubTator, text mining | PubMed |
| Amyloid arthropathy in smoldering myeloma: Do not take it lightly. | Leuk Res Rep | 2021 | 33996437 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/337/papers?page=43